X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Fulford India with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ADCOCK INGRAM
Jun-14
FULFORD INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs942399-   
Low Rs450288-   
Sales per share (Unadj.) Rs691.4118.8-  
Earnings per share (Unadj.) Rs11.5-29.9-  
Cash flow per share (Unadj.) Rs15.4-24.8-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.093.3-  
Shares outstanding (eoy) m3.90168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.02.9 34.8%   
Avg P/E ratio x60.7-11.5 -528.8%  
P/CF ratio (eoy) x45.3-13.9 -327.0%  
Price / Book Value ratio x1.83.7 49.7%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,71458,031 4.7%   
No. of employees `0000.44.3 10.3%   
Total wages/salary Rs m5053,642 13.9%   
Avg. sales/employee Rs Th6,073.04,671.9 130.0%   
Avg. wages/employee Rs Th1,137.4848.4 134.1%   
Avg. net profit/employee Rs Th100.7-1,177.2 -8.6%   
INCOME DATA
Net Sales Rs m2,69620,056 13.4%  
Other income Rs m125140 89.3%   
Total revenues Rs m2,82220,197 14.0%   
Gross profit Rs m-46-3,476 1.3%  
Depreciation Rs m15866 1.8%   
Interest Rs m10543 1.7%   
Profit before tax Rs m54-4,744 -1.1%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10296 3.2%   
Profit after tax Rs m45-5,054 -0.9%  
Gross profit margin %-1.7-17.3 9.9%  
Effective tax rate %17.7-6.2 -282.9%   
Net profit margin %1.7-25.2 -6.6%  
BALANCE SHEET DATA
Current assets Rs m1,73814,690 11.8%   
Current liabilities Rs m5458,265 6.6%   
Net working cap to sales %44.332.0 138.2%  
Current ratio x3.21.8 179.6%  
Inventory Days Days48111 43.7%  
Debtors Days Days4124 3.5%  
Net fixed assets Rs m128,563 0.1%   
Share capital Rs m3993 41.9%   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,48215,742 9.4%   
Long term debt Rs m05,532 0.0%   
Total assets Rs m2,07729,738 7.0%  
Interest coverage x6.7-7.7 -86.9%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.7 192.5%   
Return on assets %2.6-15.2 -17.2%  
Return on equity %3.0-32.1 -9.4%  
Return on capital %4.3-19.8 -21.7%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m901,712 5.3%  
From Investments Rs m105-526 -19.9%  
From Financial Activity Rs m-145,021 -0.3%  
Net Cashflow Rs m1816,207 2.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.51 Rs / ZAR

Compare FULFORD INDIA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare FULFORD INDIA With: ABBOTT INDIA  MERCK LTD  BIOCON LTD  IPCA LABS  PANACEA BIOTECH  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - STERLING BIOTECH COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS